Searched for
SUN PHARMA DOWNGRADE
Q4 earnings review: Motilal Oswal highlights broad-based beat on estimates, lists 6 sectors that exceeded expectations- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%
- From Adani Green to Tata Tech: 50 companies swing back to profit in Q4 despite market turmoil
- Buy, Sell or Hold: Citi maintains buy on Eicher Motors; Goldman Sachs retains buy on Max HealthcareBrokerages maintain a positive outlook on select large-cap pharmaceutical, automobile, and healthcare stocks, citing strong growth prospect...25 May, 2026, 09.56 AM IST
- Buy, Sell or Hold: Motilal Oswal maintains buy on UTI AMC; Goldman Sachs downgrades Dr Reddy’s LaboratoriesBrokerages remain selective, with Motilal Oswal maintaining a bullish stance on UTI AMC and Aditya Birla Sun Life AMC, citing steady AUM gr...24 Apr, 2026, 09.56 AM IST
- El Nino impact: Which stocks will burn & which will fire up as market braces for heat waveIndia faces a strong El Niño, threatening below-normal rainfall and impacting agriculture. While rural-linked sectors like two-wheelers and...24 Apr, 2026, 09.35 AM IST
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...06 Apr, 2026, 10.14 AM IST
- Sun Pharma shares slip 3% after BofA downgrade on premium valuationsBank of America downgraded Sun Pharma stock to ‘underperform’ from ‘neutral’, citing risks to premium valuations and slower speciality exec...26 Aug, 2025, 12.07 PM IST
- Stocks to buy today: IndusInd Bank gets a downgrade; Motilal Oswal sees over 20% upside in Sun PharmaNuvama has downgraded IndusInd Bank to "Reduce" citing concerns over internal derivative trades and management changes, while Antique remai...11 Mar, 2025, 10.09 AM IST
- Hot Stocks: Brokerages on TCS, Sun Pharma, HPCL, ONGC and Oil IndiaJPMorgan maintained an underweight rating on TCS with a target price of Rs 2700. TCS Q4 missed expectations across the board led by US weak...13 Apr, 2023, 10.04 AM IST
- Hot Stocks: Brokerage views on Sun Pharma, Phoenix Mills, Kotak Mahindra Bank & M&MThe stock will likely go through a period of time correction, BofA said. The global investment sees a lack of meaningful catalysts in the n...27 Mar, 2023, 09.15 AM IST
- Geojit downgrades Sun Pharma to hold, target price Rs 446Sun Pharma is India's top drugmaker and world's fifth largest specialty generic pharmaceutical company.30 Aug, 2019, 12.42 PM IST
- Goldman downgrades Sun Pharma to ‘sell’, also cuts its target priceThe downgrade led to the stock ending down 3 per cent at Rs 389.80 on Tuesday.12 Jun, 2019, 07.36 AM IST
- Sun Pharma falls 4% as Goldman Sachs downgrades stockShares of Sun Pharma traded 4.31 per cent down at Rs 384.55 on BSE.11 Jun, 2019, 03.50 PM IST
- USFDA clears Sun Pharma’s Halol plant, two years after it went under import banThe USFDA’s Establishment Inspection Report (EIR) comes days after the company received Voluntary Action Indicated (VAI) that indicated tha...12 Jun, 2018, 07.01 PM IST
- 5 global brokerages slash Sun Pharma targetsTop brokerages have scaled down their 12-month target price and EPS estimates for Sun Pharma, after the firm received a warning letter from...21 Dec, 2015, 10.26 AM IST
- Shares of Sun Pharma dips 15% after profit warning triggers downgradesShares of India’s largest pharmaceutical company Sun Pharma slumped 15% to Rs 805 on Tuesday—its biggest single-day dropever—after profit w...22 Jul, 2015, 04.01 AM IST
- Sun Pharma slips on profit warnings ahead of June quarter resultsSun Pharma Ltd slipped over 15% in intraday trade. The company said that its revenue in fiscal year 2016 would be flat.21 Jul, 2015, 09.39 AM IST
- Top pharma stocks fall on Bank of America Merrill Lynch ratings downgradeThe brokerage downgraded its rating on Sun to ‘underperform’, and on Lupin, Cipla and Cadila to ‘neutral’ from ‘buy’.10 Apr, 2015, 04.51 AM IST
- Pharma stocks fall after BofA-ML downgradePharma cos including Sun Pharma, Lupin, Cadila Healthcare and Cipla weakened on Thursday after BofA-ML's downgrade.09 Apr, 2015, 04.08 PM IST
Load More
